arimoclomol has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguila, M; Athanasiou, D; Bevilacqua, D; Cheetham, ME; Coffey, PJ; Greensmith, L; Kalmar, B; Kanuga, N; McCulley, CH; Mendes, HF; Munro, PM; Novoselov, SS; Parfitt, DA | 1 |
| Arenz, C; Atkins, J; Begley, D; Bornæs, C; Drndarski, S; Gray, J; Hinsby, A; Ingemann, L; Jäättelä, M; Jørgensen, SH; Kirkegaard, T; Klein, A; Morris, L; Olsen, OD; Petersen, NH; Platt, FM; Priestman, DA; Smith, DA; Wallom, KL; Williams, I | 1 |
| Cheetham, ME; Gray, A; Greensmith, L; Kalmar, B; Margulis, B; Novoselov, S | 1 |
| Edet-Amana, E; Greensmith, L; Kalmar, B | 1 |
| Dick, J; Greensmith, L; Kalmar, B; Lu, CH; Malaspina, A; Petzold, A | 1 |
| Gray, AL; Greensmith, L; Hanna, MG; La Spada, AR; Malik, B; Nirmalananthan, N | 1 |
| Benn, SC; Brown, RH | 1 |
7 other study(ies) available for arimoclomol and Disease Models, Animal
| Article | Year |
|---|---|
The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa.
Topics: Animals; Cell Line; Cell Survival; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Heat-Shock Response; Humans; Hydroxylamines; Mutation; Photoreceptor Cells, Vertebrate; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Retinal Degeneration; Retinitis Pigmentosa; Rhodopsin; Time Factors; Transfection; Unfolded Protein Response; Vision, Ocular | 2014 |
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses.
Topics: Administration, Intravenous; Animals; Blood-Brain Barrier; Bone Morphogenetic Proteins; Disease Models, Animal; Disease Progression; Fabry Disease; Fibroblasts; Glycosphingolipids; Heat-Shock Proteins; Humans; Hydroxylamines; Injections, Intraperitoneal; Intracellular Signaling Peptides and Proteins; Lysosomes; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Proteins; Recombinant Proteins; Sphingolipidoses; Tissue Distribution | 2016 |
Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; Female; HSP70 Heat-Shock Proteins; Humans; Hydroxylamines; Male; Mice; Mice, Transgenic; Motor Neurons; Muscle, Skeletal; Spinal Cord; Statistics, Nonparametric; Superoxide Dismutase; Survival Analysis; Ubiquitin | 2008 |
Treatment with a coinducer of the heat shock response delays muscle denervation in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Topics: Acetylcholinesterase; Amyotrophic Lateral Sclerosis; Animals; Choline O-Acetyltransferase; Disease Models, Animal; Disease Progression; GPI-Linked Proteins; Heat-Shock Response; HSP70 Heat-Shock Proteins; Hydroxylamines; Longitudinal Studies; Mice; Mice, Transgenic; Motor Neurons; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Neuromuscular Junction; Succinate Dehydrogenase; Superoxide Dismutase | 2012 |
Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Biomarkers; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Hydroxylamines; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscles; Neurofilament Proteins; Phosphorylation; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Outcome | 2012 |
Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.
Topics: Animals; Blotting, Western; Disease Models, Animal; Disease Progression; Heat-Shock Proteins; Heat-Shock Response; Hydroxylamines; Male; Mice; Muscular Disorders, Atrophic; Neuroprotective Agents; Real-Time Polymerase Chain Reaction | 2013 |
Putting the heat on ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Heat-Shock Response; Hydroxylamines; Life Expectancy; Mice; Superoxide Dismutase | 2004 |